Hot Features
Premium
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Période:
Mode Dessin:
| Volume | 43 597 |
|
|||||
| Actualités | - | ||||||
| Maximum Haut | 0,813038 | Bas Haut |
|||||
| Minimum Bas | 0,74 | ||||||
| Nom Action | Symbole Action | Marché | Type |
|---|---|---|---|
| Virpax Pharmaceuticals Inc | VRPX | NASDAQ | Action ordinaire |
| Variation Action | Variation Action% | Cours Dernier | Dernier échange
|
|
|---|---|---|---|---|
| -0,0805 | -10,06% | 0,72 | 06:00:08 |
| Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
|---|---|---|---|---|
| 0,81 | 0,74 | 0,813038 | 0,7501 | 0,8005 |
| Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
|---|---|---|---|---|---|
| 219 | 43 597 | US$ 0,7736889 | US$ 33 731 | - | 0,6316 - 11,774 |
| Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
|---|---|---|---|---|
| 00:51:42 | 50 | US$ 0,749 | USD |
Bilan Comptable
| Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
|---|---|---|---|---|---|---|
| 878,57k | 1,17M | - | 0 | -15,19M | -12,97 | - |
| Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
plus d’informations financières »
Actualités Action Virpax Pharmaceuticals
| Date | Heure | Source | Titre |
|---|---|---|---|
| 29/5/2024 | 13:30 | Business Wire | Virpax® Pharmaceuticals to Present at 2024 BIO International.. |
| 17/5/2024 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 16/5/2024 | 22:00 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
| 15/5/2024 | 14:00 | Business Wire | Virpax Announces Pricing of $2.25 Million Public Offering |
| 15/5/2024 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 13/5/2024 | 23:30 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
| 13/5/2024 | 22:20 | Edgar (US Regulatory) | Form 8-K - Current report |
| 13/5/2024 | 22:10 | Business Wire | Virpax Pharmaceuticals Reports 2024 First Quarter Results.. |
| 13/5/2024 | 22:02 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 30/4/2024 | 13:30 | Business Wire | Virpax Announces Results of Maximum Tolerated Dose Study for.. |
| 26/3/2024 | 12:30 | Business Wire | Virpax Pharmaceuticals Reports 2023 Year-End Results |
| 27/2/2024 | 13:31 | Business Wire | Virpax Pharmaceuticals Announces Reverse Stock Split to.. |
Forum Action Virpax Pharmaceuticals
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Virpax Pharmaceuticals Inc
| Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
|---|---|---|---|---|---|---|---|
| 1 semaine | 0,73 | 0,83 | 0,649 | 0,7597605 | 104 069 | -0,01 | -1,37% |
| 1 mois | 2,61 | 3,14 | 0,6316 | 0,8360314 | 259 709 | -1,89 | -72,41% |
| 3 mois | 3,77 | 4,825 | 0,6316 | 1,13 | 95 519 | -3,05 | -80,90% |
| 6 mois | 3,70 | 5,48 | 0,6316 | 3,12 | 194 432 | -2,98 | -80,54% |
| 1 an | 8,40 | 11,774 | 0,6316 | 3,87 | 116 905 | -7,68 | -91,43% |
| 3 ans | 48,80 | 359,799 | 0,6316 | 103,12 | 711 859 | -48,08 | -98,52% |
| 5 ans | 80,00 | 359,799 | 0,6316 | 101,82 | 662 449 | -79,28 | -99,10% |
